Insights

Innovative Therapeutics Liminal BioSciences specializes in developing novel small molecule therapeutics targeting GPCR pathways, which addresses significant unmet medical needs in metabolic, inflammatory, and fibrotic diseases. This focus creates opportunities for partnerships or collaborations with pharma companies seeking innovative treatments in these high-growth areas.

Recent Acquisition The company's impending acquisition by Structured Alpha indicates potential for expansion and increased resources, making it an attractive prospect for partners looking to engage with a company on the cusp of leveraging new capital or strategic support.

Geographic Presence With talent hubs in Quebec and the UK and operations in Ontario, Liminal offers regional access to North American and European biotech ecosystems, providing multiple avenues for regional partnerships, research collaborations, or clinical development initiatives.

Financial Profile While the company has modest revenue between 1M and 10M and recent funding of 1.8M, its ongoing development-stage status presents growth opportunities for investors or collaborators interested in early-stage biopharmaceutical innovation.

Technology Stack Utilizing advanced digital tools like Cloudflare CDN, SEO platforms, and analytics, Liminal demonstrates an active digital presence and technological sophistication, which could facilitate outreach, digital partnerships, or collaborative research leveraging their tech-enabled approach.

Liminal BioSciences Tech Stack

Liminal BioSciences uses 8 technology products and services including Matomo, jsDelivr, Cloudflare CDN, and more. Explore Liminal BioSciences's tech stack below.

Matomo

Analytics

jsDelivr

Content Delivery Network

Cloudflare CDN

Content Delivery Network

RSS

Content Management System

oEmbed

Dev Tools

Slick

Javascript Libraries

PHP

Programming Languages

RankMath SEO

Web Platform Extensions

Liminal BioSciences Email Formats	Example	Percentage
F.Last@liminalbiosciences.com	J.Doe@liminalbiosciences.com	50%
F.Last@liminalbiosciences.com	J.Doe@liminalbiosciences.com	50%

Liminal BioSciences Email Formats

Example

Percentage

F.Last@liminalbiosciences.com

J.Doe@liminalbiosciences.com

50%

F.Last@liminalbiosciences.com

J.Doe@liminalbiosciences.com

50%

Frequently Asked Questions

Where is Liminal BioSciences's headquarters located?

Liminal BioSciences's main headquarters is located at 440 Boulevard Armand-Frappier, Suite 300 Laval, Quebec H7V 4B4, CA. The company has employees across 2 continents, including North AmericaEurope.

What is Liminal BioSciences's official website and social media links?

Liminal BioSciences's official website is liminalbiosciences.com and has social profiles on LinkedIn Crunchbase.

What is Liminal BioSciences's SIC code NAICS code?

Liminal BioSciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Liminal BioSciences have currently?

As of October 2025, Liminal BioSciences has approximately 22 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: B. P.President: P. S.Associate Director, Nonclinical Safety And Dmpk: A. A.. Explore Liminal BioSciences's employee directory with LeadIQ.

What industry does Liminal BioSciences belong to?

Liminal BioSciences operates in the Biotechnology Research industry.

What technology does Liminal BioSciences use?

Liminal BioSciences's tech stack includes MatomojsDelivrCloudflare CDNRSSoEmbedSlickPHPRankMath SEO.

What is Liminal BioSciences's email format?

Liminal BioSciences's email format typically follows the pattern of F.Last@liminalbiosciences.com. Find more Liminal BioSciences email formats with LeadIQ.

How much funding has Liminal BioSciences raised to date?

As of October 2025, Liminal BioSciences has raised $1.8M in funding. The last funding round occurred on Jul 16, 2020 for $1.8M.

Liminal BioSciences

Q: How many employees does Liminal BioSciences have currently?

Liminal BioSciences has approximately 22 employees.

Q: What technology does Liminal BioSciences use?

Liminal BioSciences's tech stack includes Google Tag Manager, Cloudflare Bot Management, Office 365, Webpack, jQuery.

Biotechnology ResearchCanada11-50 Employees

Liminal BioSciences, through its wholly owned subsidary, Caledon Bioscience Inc., is a data-driven development-stage biopharmaceutical company focused on discovering and developing novel and distinctive small molecule therapeutics that modulate G protein-coupled receptor pathways (GPCRs). We are designing proprietary novel small molecule therapeutic candidates with the intent of developing best/first in class therapeutics for the treatment of metabolic, inflammatory and fibrotic diseases with significant unmet medical needs, using our drug discovery  and medicinal chemistry expertise and deep understanding of GPCR biology.

Our registered office is located in Belleville, Ontario and we have talent hubs in Quebec, Canada, and in the United Kingdom. 

See our social media community guidelines at https://liminalbiosciences.com/social-media-community-guidelines/

Insights

Similar companies to Liminal BioSciences

Akari Therapeutics PLC